Recent Updates
Recently added Catalysts
CLDX Positive Sentiment Score: 70/100

Celldex to Present at Morgan Stanley 23rd Annual Global Healthcare Conference

Tuesday, September 9, 2025 1 min read
Key Takeaway: Celldex Therapeutics, Inc. will participate in a fireside chat at the Morgan Stanley 23rd Annual Global Healthcare Conference on September 9, 2025. The event is scheduled for 3:20 pm ET, and a live webcast will be available on their website. A replay will be accessible for 90 days post-event.
Price reaction · baseline $23.4 (2025-09-08 close) · hit pre-market · clean, no other CLDX news in the window
day 0 close · peak
+3.8%

Market Sentiment Analysis

POSITIVE FACTORS

  • Celldex is actively engaging with investors at a major healthcare conference.
  • The company is focused on pioneering new therapies in immunology.
  • The live webcast allows broader access to their presentation.

Full Press Release Details

HAMPTON, N.J., Sept. 09, 2025 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (NASDAQ:CLDX) announced that management will participate in a fireside chat today, September 9th, 2025, at the Morgan Stanley 23rd Annual Global Healthcare Conference at 3:20 pm ET. A live webcast of the presentation will be available on the "Events & Presentations” page of the "Investors" section of theCelldex website. A replay will be available for 90 days following the event.
About CelldexCelldex is pioneering new horizons in immunology to deliver life-changing therapies. We are relentless in our pursuit of novel antibody-based treatments that engage the human immune system and directly affect critical pathways to improve the lives of patients with allergic, inflammatory and autoimmune disorders. Visitwww.celldex.com.

Company ContactSarah CavanaughSenior Vice President, Corporate Affairs & Administration(508) 864-8337scavanaugh@celldex.com

Frequently Asked Questions

When is Celldex's presentation at the conference?

Celldex's presentation is scheduled for September 9, 2025, at 3:20 pm ET.

Where can I watch the Celldex presentation?

The presentation will be available via a live webcast on the Celldex website.

How long will the presentation replay be available?

The replay of the presentation will be available for 90 days after the event.

What is Celldex focusing on in their research?

Celldex is focused on developing novel antibody-based therapies in immunology.

Tags: CLDX Viatris Investor Conferences Healthcare Celldex Morgan Stanley Healthcare Conference immunology investors
Last updated: Sep 9, 2025

Biotech snapshot

Cash runway
$451M liquidity · $22M/mo burn
~18 mo
Low dilution risk
Lead asset
barzolvolimabPhase 3
Chronic Inducible Urticaria →

Catalyst track record

+70%
best trade around CLDX's most recent catalyst

Peak hindsight return over a 120-day window, across 5 tracked FDA/PDUFA catalysts for CLDX.

See every catalyst's timing & PoA →